This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Hemotransmissive Infections Testing Market

Market Insights on Hemotransmissive Infections Testing covering sales outlook, demand forecast & up-to-date key trends

Hemotransmissive Infections Testing Market By Test Type (Hepatitis B Virus DNA Test, Hepatitis C Virus RNA Test), Indication (Hepatitis B, Hepatitis C and Human Immunodeficiency Virus), End User (Hospitals, Diagnostic Laboratories and Clinics) & Region - Forecast 2022-2032

Hemotransmissive Infections Testing Market Overview

Global hemotransmissive infections testing demand is anticipated to be valued at US$ 2 Billion in 2022, forecast to grow at a CAGR of 11.61% to be valued at US$ 6 Billion from 2022 to 2032.

Report Attribute

Details

Estimated Base Year Value (2021)

US$ 1.5 Billion

Expected Market Value (2022)

US$ 2 Billion

Anticipated Forecast Value (2032)

US$ 6 Billion

Projected Growth Rate (2022-2032)

11.61% CAGR

Hemotransmissive infections are infections that spread through blood when an infected person comes into contact with another infected person. The most common diseases spread through blood are hepatitis C, hepatitis B, and the human immunodeficiency virus (HIV). It is critical to diagnose these diseases as soon as possible in order to treat or manage them.

The hemotransmissive infections testing market is undergoing regulatory changes from the government of the respective region or country, such as in December 2018, the government of the United States updated law regarding age and consent of diagnosis, i.e. minors aged 15 to 18 years can now be tested without the consent of their legal guardian or parents, which can increase the possibility of early diagnosis in patients under the age of 18 years.

According to the European Centre for Disease Prevention and Control and WHO, HIV infections have increased significantly in Eastern Europe, with over 130,000 people infected in 2016, whereas HIV infection has decreased by nearly 20.0% in Western Europe. Similarly, as the prevalence of hepatitis C and hepatitis B rises, hemotransmissive infections testing can play an important role in early diagnosis.

Which are Some Prominent Drivers Spearheading Hemotransmissive Infections Testing Market Growth?

The rising prevalence of HIV in the developing world, owing to a lack of knowledge about preventive measures, is expected to fuel the growth of the hemotransmissive infections testing market. Despite the fact that the prevalence of HIV is rising, government initiatives such as free HIV testing are expected to drive the growth of the hemotransmissive infections testing market.

According to the WHO, there are approximately 71.0 million people worldwide who have hepatitis C, and 399,000 people die from it each year. The general public's growing awareness of the symptoms and diagnostic measures is expected to fuel the growth of the hemotransmissive infections testing market. Similarly, hepatitis B can be fatal if not detected in time, indicating that the hemotransmissive infections testing market has significant revenue generation potential.

Various initiatives by the government, non-profit organizations, and healthcare professionals can improve the timely diagnosis of these diseases with hemotransmissive infections testing kits, thereby driving the hemotransmissive infections testing market growth.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Challenges Faced by the Hemotransmissive Infections Testing Industry?

The high cost of hemotransmissive infections testing may stymie the hemotransmissive infections testing market's potential growth.

Why is Asia-Pacific Emerging as an Opportunistic Hemotransmissive Infections Testing Market?

The Asia-Pacific hemotransmissive infections testing market is growing as patient awareness grows and various government initiatives for early diagnosis of hemotransmissive infections are implemented.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Europe Contributing to Growth of the Hemotransmissive Infections Testing Market?

According to Future Market Insights, Because of the rising prevalence of hemotransmissive infections, Europe's hemotransmissive infections testing market is expected to be the second most lucrative.

Market Competition

AO Vector-Best, Atlas Medical Uk, Launch Diagnostics, Creative Diagnostics, Shanghai Chemtron Biotech, Oscar Medicare, MyBioSource.com, ABON Biopharm (Hangzhou), Bio-Rad Laboratories, Trinity Biotech Manufacturing Ltd, and others are the key players in the global hemotransmissive infections testing market.

Attributed to the presence of such high number of participants, the market is highly competitive.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 11.61% from 2022 to 2032

Base Year for Estimation

2021

Historical Data

2015-2020

Forecast Period

2022-2032

Quantitative Units

Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Test Type
  • Indication
  • End User
  • Region

Regions Covered

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East and Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Poland
  • Russia
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • AO Vector-Best
  • Atlas Medical UK
  • Launch Diagnostics
  • Creative Diagnostics
  • Shanghai Chemtron Biotech
  • Oscar Medicare
  • MyBioSource.com
  •  ABON Biopharm (Hangzhou)
  • Bio-Rad Laboratories
  • Trinity Biotech Manufacturing Ltd

Customization

Available Upon Request

Key Segments Profiled in the Hemotransmissive Infections Testing Industry Survey

Test Type:

  • Hemotransmissive Infections for Hepatitis B Virus (HBV) DNA Test
  • Hemotransmissive Infections for Hepatitis C Virus (HCV) RNA Test
  • Hemotransmissive Infections for Human Immunodeficiency Virus (HIV) Types 1 and 2 RNA Test

Indication:

  • Hepatitis B Hemotransmissive Infections Testing
  • Hepatitis C Hemotransmissive Infections Testing
  • Human Immunodeficiency Virus (HIV) Hemotransmissive Infections Testing

End Userv

  • Hemotransmissive Infections Testing in Hospitals
  • Hemotransmissive Infections Testing in Diagnostic Laboratories
  • Hemotransmissive Infections Testing in Clinics

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

Frequently Asked Questions

FMI projects the global Hemotransmissive Infections Testing market to expand at an 11.61% value CAGR by 2032

Asia Pacific is expected to be the most opportunistic Hemotransmissive Infections Testing market.

AO Vector-Best, Atlas Medical Uk, Launch Diagnostics and Creative Diagnostics, are some prominent Hemotransmissive Infections Testing manufacturers

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Hemotransmissive Infections Testing Market